An Evaluation of -Omics Technology
Omics technologies have proven to be useful molecular tools across many therapeutic areas in facilitating qualitative and quantitative tissue analysis. Spatially Resolved Transcriptomics (SRT) is an example of -omics technology used in oncology to further investigate how the heterogeneity of...
4 years agoAn Evaluation of -Omics Technology
Omics technologies have proven to be useful molecular tools across many therapeutic areas in facilitating qualitative and quantitative tissue analysis. Spatially Resolved Transcriptomics (SRT) is an example of -omics technology used in oncology to further investigate how the heterogeneity of...
4 years ago
Future Trends for Pharma and Life Sciences 2021
Given the considerable seismic shifts occurring in the pharmaceutical and life sciences sectors recently, it is no surprise that the major trends and investments of 2021 have seen a similar change in focus. Alzheimer’s Disease, genome editing and cellular therapy...
4 years agoFuture Trends for Pharma and Life Sciences 2021
Given the considerable seismic shifts occurring in the pharmaceutical and life sciences sectors recently, it is no surprise that the major trends and investments of 2021 have seen a similar change in focus. Alzheimer’s Disease, genome editing and cellular therapy...
4 years ago
The Challenges of Paediatric Cancer Treatment
The rarity of childhood cancer makes it difficult to develop therapeutic treatment for patients. Small patient populations impact the logistics and execution of clinical trials investigating novel therapies. It appears, however, that the pharmaceutical industry especially experiences a number of...
4 years agoThe Challenges of Paediatric Cancer Treatment
The rarity of childhood cancer makes it difficult to develop therapeutic treatment for patients. Small patient populations impact the logistics and execution of clinical trials investigating novel therapies. It appears, however, that the pharmaceutical industry especially experiences a number of...
4 years ago
Strategies to Optimise Companion Diagnostics in Cancer
Companion diagnostic tests are an important part of precision medicine in oncology. In addition to matching optimal treatment options for patients, these tests enable clinicians to monitor the efficacy of therapeutic intervention in disease management. Innovations in cancer biopsies and...
4 years agoStrategies to Optimise Companion Diagnostics in Cancer
Companion diagnostic tests are an important part of precision medicine in oncology. In addition to matching optimal treatment options for patients, these tests enable clinicians to monitor the efficacy of therapeutic intervention in disease management. Innovations in cancer biopsies and...
4 years ago
Precision Medicine in Oncology: A Comparative Evaluation of SMDCs and ADCs
Targeted therapy - a treatment targeting proteins responsible for cancer growth - is one of the latest developments in precision oncology. The variable response of cancer treatments highlights the need to develop therapies that can target the specific profile of...
4 years agoPrecision Medicine in Oncology: A Comparative Evaluation of SMDCs and ADCs
Targeted therapy - a treatment targeting proteins responsible for cancer growth - is one of the latest developments in precision oncology. The variable response of cancer treatments highlights the need to develop therapies that can target the specific profile of...
4 years ago
Optimising Screening Strategies and Early Detection of Cancer: A Challenge for Pharma and Clinical Industries
Screening methods in oncology are critical to enable doctors to detect cancer in at-risk populations. Early detection of the disease is essential to choose appropriate treatment to increase the chance of survival. The latest research identifies flaws in clinical screening...
4 years agoOptimising Screening Strategies and Early Detection of Cancer: A Challenge for Pharma and Clinical Industries
Screening methods in oncology are critical to enable doctors to detect cancer in at-risk populations. Early detection of the disease is essential to choose appropriate treatment to increase the chance of survival. The latest research identifies flaws in clinical screening...
4 years ago
Innovations addressing the challenges of oncology clinical research to treat rare and ultra-rare diseases
Rare cancers are notoriously difficult to study and present a critical problem in clinical research. Innovations to clinical trial design and patient recruitment are some of the many changes in the field to optimise the outcome of clinical trials for...
4 years agoInnovations addressing the challenges of oncology clinical research to treat rare and ultra-rare diseases
Rare cancers are notoriously difficult to study and present a critical problem in clinical research. Innovations to clinical trial design and patient recruitment are some of the many changes in the field to optimise the outcome of clinical trials for...
4 years ago
Are CAR-T and TCR Therapies The Future for Cancer Patients?
Cancer represents one of the most complex diseases in the world. The vast number of cancer types that vary in pathology and response to treatment continue to pose a problem. CAR-T and TCR therapies represent the next step in developing...
4 years agoAre CAR-T and TCR Therapies The Future for Cancer Patients?
Cancer represents one of the most complex diseases in the world. The vast number of cancer types that vary in pathology and response to treatment continue to pose a problem. CAR-T and TCR therapies represent the next step in developing...
4 years ago
Evaluating The Efficacy of Therapeutic Oncology Vaccines in Cancer Treatment
The development of anti-cancer vaccines is supported by many studies which prove the efficacy of immunotherapy against cancer. Cancer vaccines are also the beginning of preventative treatment for many cancer types, offering hope for susceptible patient populations. The latest advancements...
4 years agoEvaluating The Efficacy of Therapeutic Oncology Vaccines in Cancer Treatment
The development of anti-cancer vaccines is supported by many studies which prove the efficacy of immunotherapy against cancer. Cancer vaccines are also the beginning of preventative treatment for many cancer types, offering hope for susceptible patient populations. The latest advancements...
4 years ago
Innovations in Oncology Today: An Interview with Jessicca Rege
Even aside from the COVID-19 pandemic, 2020 saw a number of innovations in the oncology space, from novel cytokine development to use of NGS to further patient-centric treatment. We spoke to Jessicca Rege, Vice President and Head of Oncology at...
4 years agoInnovations in Oncology Today: An Interview with Jessicca Rege
Even aside from the COVID-19 pandemic, 2020 saw a number of innovations in the oncology space, from novel cytokine development to use of NGS to further patient-centric treatment. We spoke to Jessicca Rege, Vice President and Head of Oncology at...
4 years ago